Option Care Health, Inc.

Fundamentals6.5
Price Action6.0
News Sentiment6.0
AI Rating
6.0

Key Drivers

  • Cash Conversion
  • Margin Stability
  • Balance Sheet Risk

AI
AI Summary

6.0

OPCH has shifted from a post-miss freefall story to a credible repair-and-rebuild setup where improving EBITDA/EPS and strong cash flow create upside if management can sustain margin gains and stabilize guidance, but the investment remains constrained by leverage and the securities-law overhang, making another clean quarter the key trigger for re-rating.

MarginRecovery
ExecutionRisk
Valuation‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

6.5

Key Financial Insights:

  • Cash Conversion
  • Margin Stability
  • Balance Sheet Risk

OPCH shows decent cash-backed profitability and improved valuation, but its investment appeal is restrained by meaningful leverage, only moderate liquidity, and a balance sheet heavily dependent on intangibles. ക

leverage
valuation

Price Behavior

6.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Higher highs
  • Breakout pause
  • Support intact

Over the last month, OPCH has stayed in a constructive uptrend with higher highs and higher lows and a roughly 10% gain, but momentum has paused after the $24.50 breakout attempt and now needs a fresh move above that resistance to extend higher.

bullish
neutral
Support Level: $23.6–$23.7
Resistance Level: $24.50

Pullback from $24.50 to $23.95 after the late breakout attempt

Sentiment & News

6.0

Key News Insights:

  • Q2 beat
  • Narrowed outlook
  • Mixed ownership

OPCH posted better-than-expected Q2 results with sequential growth, narrowed guidance, and continued investor attention despite mixed institutional moves.

earnings
guidance

The news is mildly bullish for OPCH as improving execution and steady guidance support sentiment, though institutional selling could temper upside